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Seizure control is often affected by seizure threshold lowering behaviours. In this case report, the authors address excessive
caffeine ingestion from tea with increased seizure frequency. When decaffeinated beverages were substituted for the tea, seizure
frequency returned to baseline. Similar findings occurred when the patient was re-challenged. The authors recommend avoidance
of excessive caffeine in patients with epilepsy.
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INTRODUCTION
Lack of seizure control can be related to a series of
issues: complexity of seizure disorder, inappropriate
anticonvulsant for the particular seizure disorder, and
concomitant medical illnesses with fevers1–5. With the
plethora of recently released anticonvulsants, uncon-
trolled seizure frequency often leads to a change in
prescribed anticonvulsant. What may be overlooked in
this rush to use the newer agents are the fundamentals
in seizure control—compliance, therapeutic anticon-
vulsant blood levels, and the avoidance of threshold
lowering behaviours1.
Seizure threshold is decreased by: decreased
sleep4, 6; excessive stress4, 7; threshold lowering medi-
cations5, 8–12; medications with pharmacokinetic in-
teractions with anticonvulsants13, 14 or threshold
lowering substances15, 16; and caffeine17–20.
Literature suggests that patients with epilepsy
should avoid caffeinated beverages15, 21, but the only
report concerning the proconvulsive effect of tea was
a study with mice22. In this case report, accidental
increase in seizure frequency associated with exces-
sive tea ingestion is noted that resolved when decaf-
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feinated beverages were substituted. This finding was
duplicated when the patient was re-challenged with
the caffeinated beverage.
CASE
A 49-year-old white male with a 36-year history of
mixed seizure disorder (grand mal seizures with inter-
mittent auras, absence seizures, atonic seizures, and
myoclonic seizures) who had been well controlled on
phenytoin 400 mg once daily and primidone 500 mg
once daily developed a sharp increase in myoclonic
and atonic seizure frequency. Anticonvulsant com-
pliance had been maintained with therapeutic blood
levels. A pill count revealed that no anticonvulsants
had been missed. There had been no change in
sleep patterns or level of stress. Further, the patient
had no concurrent illnesses or addition of medica-
tions. Change in anticonvulsants to newer agents was
contemplated. Prior to doing such, a review of the
patient’s diet revealed a recent increase in caffeinated
beverages. In an effort to avoid caloric beverages, the
patient was drinking 4 pints of “Peach diet Snapple
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Iced Tea” daily. Further, this was typically consumed
within 180 minutes. The increased seizure frequency
continued over a 2-month time period until the
patient’s wife commented upon the potential influ-
ence of the additional caffeinated beverages. When
the “Peach diet Snapple Iced Tea” was changed to
the decaffeinated “Kiwi Strawberry Cocktail diet
Snapple”, the patient’s seizure frequency returned
to baseline. This simple change in diet obviated the
need to change anticonvulsants to control seizure
frequency.
The patient thereafter found that he could drink 1
pint of “Peach diet Snapple Iced Tea” without any
effect on seizure frequency. When 4 years later he
re-challenged himself briefly with 4 pints of “Peach
diet Snapple Iced Tea”, the blinded wife again com-
mented on the return of myoclonic activity and queried
his compliance. Again with immediate reduction to 1
pint or use of decaffeinated beverages, no further my-
oclonus was noted.
DISCUSSION
Toxicity and seizures associated with over-the-counter
stimulants, including caffeine, have been reported23;
however, this case is unique in that seizures associ-
ated solely with excessive tea ingestion have not been
previously reported. Nonetheless, it is important to re-
alise that numerous beverages contain caffeine and, as
such, it is the cumulative caffeine from all beverages
ingested that matters.
As a solitary case, the findings from this case can-
not be generalised. Further limitations of this case in-
clude the lack of caffeine blood levels and the lack of
quantitative myoclonic frequency. However, the fact
that the myoclonus returned when the patient was
re-challenged is noteworthy and supports the theory
that caffeine was the aetiologic factor.
The total time associated with ingestion of caf-
feinated beverages may be pertinent to the procon-
vulsive effect of caffeine. In one rat study of caffeine
augmentation of electroconvulsive seizures, the pro-
convulsive effect was dose dependent and lasted for
at least 230 minutes19. Thus it is important that the
patient had ingested the caffeinated beverages within
180 minutes.
Since caffeine is metabolised by cytochrome P450
1A2, saturation of this enzyme (which could occur
with high consumptions of caffeine, and may have oc-
curred in this case) or inhibition of this enzyme will
result in increased toxicity from caffeine15. This is a
critical issue for clinicians as selective serotonin re-
uptake inhibitors, antiarrhythmics, antipsychotics, and
bronchodilators all have been reported to inhibit this
enzyme15.
Pharmacokinetic studies have shown that caffeine
does not affect standard anticonvulsant blood lev-
els (carbamazepine, valproate, phenobarbitone, and
phenytoin) and that protective qualities of these an-
ticonvulsants are progressively reduced with chronic
caffeine exposure18, 21, 24. In this case, the patient was
on phenytoin and primidone (the latter metabolises to
phenobarbitone).
Although this case report has focused on caffeine
(1,3,7-trimethylxanthine) in tea, it should be noted that
tea also includes theobromine (3,7-dimethylxanthine)
and theophylline (1,3-dimethylxanthine)25, 26. All
three methylxanthines, which are ubiquitous in bev-
erage and food preparations, have been shown to
have proconvulsive features27. As such, the au-
thors speculate that in addition to caffeine, pa-
tients with epilepsy should avoid all unnecessary
dietary sources of methylxanthines. In fact, the
dietary presence of methylxanthines dates to the
preclassic Maya civilisation28. Finally, in patients
wherein dietary issues (excessive methylxanthines)
are felt to contribute to the lack of seizure con-
trol, levels of these three methylxanthines should be
determined29.
CONCLUSION
The authors have observed that the newer anticonvul-
sants are important to control epilepsy and in many
instances have better side effect profiles than the older
agents. Nonetheless, the use of these agents does not
permit the practitioner and the patient to forget the
fundamentals of epilepsy control, specifically min-
imisation of seizure threshold lowering behaviours in-
cluding excessive caffeinated beverages. In this case,
the simple elimination of excessive caffeinated bev-
erages obviated the need to change anticonvulsants to
improve seizure control.
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